InvestorsHub Logo
icon url

CaptBeer

10/30/23 9:41 AM

#417254 RE: Pharmacydude #417253

I disagree with #4. My GP is in charge of all my health including CV. I don’t even have a cardiologist. He’ll send me to a specialist if we think it warrants one. GP’s need to be educated like I did mine.
icon url

noelan_s09

10/30/23 10:04 AM

#417255 RE: Pharmacydude #417253

My GP prescribes Vascepa for my wife and I both. My cardiologist hadn’t even heard of it when I asked him about it two years ago.

Noel
icon url

Triple88

10/30/23 11:16 AM

#417265 RE: Pharmacydude #417253

PharmacyDude
Thank you for your ongoing excellence in the science of Omega 3's (and Vascepa) !!
Your predictions for management behavior have been almost dead on !!
In Canada, do you believe the new CEO, Craig Millian, will be able to ramp up Vascepa's sales to achieve sales north of $100MM+ long term.
And I would be very interested in your perspective on the key specific actions plans that are necessary for Canada (and now the EU) to be successful !
Will EU be able to match or beat Canadian roll out curves
Thank you for any perspectives you are willing to share, and please continue your excellence work and efforts!
icon url

Nukemtiltheyglow

10/30/23 1:31 PM

#417269 RE: Pharmacydude #417253

Only 3 years experience with Vascepa? And here we all thought you were an expert?

I disagree with #3 and #4;

"V doesn't change or fix anything?" Really?

My Primary Care medical person is a Registered Nurse (thank God!) Someone with a little common sense who's been trained very well by a local Cardiologist I might add who's an advocate of Vascepa use. And no, I don't have a cardiologist. My Nurse makes all the calls.
icon url

Birdbrain Ideas

10/30/23 1:35 PM

#417270 RE: Pharmacydude #417253

Your XBI paragraph gives me hope that there isn't something really grisly, like a loss between $50 million and $100 million, in the forecast for Wednesday morning. And since I consider you and CaptBeer the smartest and best-informed posters on the board, I'll cling to that hope.

Maybe it's just the approach of Halloween, but the share price movement does leave me a little spooked since it seems to mimic what happened before the earnings announcements in the really ugly quarters last year. Not high volume trading, but an unmistakable slow and steady erosion.